Target intelligence / Profile preview

Clostridium chauvoei (C. chauvoei)

Target
C. chauvoei
Molecular classification
Other
01

Overview

Clostridium chauvoei is a Gram-positive, anaerobic, spore-forming bacterium that is the primary causative agent of blackleg (also known as black quarter), a highly fatal myonecrosis in cattle and other ruminants (Frey et al., 2012; VetBact.org). The organism persists in the environment as resilient spores that can remain latent in animal tissues until triggered by anaerobic conditions, such as muscle trauma (Uzal, 2012; OSU.edu). Upon germination, the vegetative bacteria produce several potent toxins, most notably Clostridium chauvoei toxin A (CctA), a beta-barrel pore-forming toxin that is the major virulence factor responsible for tissue destruction and systemic toxemia (Frey et al., 2012; Nicholson et al., 2019). Other virulence factors include sialidases (NanA), hyaluronidases, and DNases, which contribute to the disorganization of muscle tissue (Vilei et al., 2011; Falquet et al., 2013). While antibiotics like penicillin and gentamicin can be effective in vitro, the rapid progression of the disease often makes clinical treatment futile, leading to death within 24 to 48 hours (Banglajol.info; SkyVetPharm.com). Consequently, control relies heavily on prophylactic vaccination with bacterin-toxoids that induce neutralizing antibodies against CctA and other cellular antigens (Nicholson et al., 2019; ResearchGate.net).

Other names
Clostridium feseriBlackleg bacteriumClostridium chauvei
02

Mechanism of action

Antibiotics such as penicillin inhibit bacterial cell wall synthesis, while gentamicin inhibits protein synthesis; vaccines primarily target the CctA toxin to neutralize its pore-forming activity (Nicholson et al., 2019; Banglajol.info).

03

Biological functions

Toxin productionSpore formationAnaerobic metabolismMyonecrosis induction
04

Disease associations

InfectionBlacklegMyonecrosisGas gangrene
05

Safety considerations

Rapid disease progressionHigh mortality rateEnvironmental persistence of sporesAntibiotic resistance
06

Interacting drugs

Penicillin

2 more in the full profile.

07

Biomarkers

Clostridium chauvoei toxin A (CctA)16S rRNAFlagellin antigens

Beyond the preview

Go deeper on Clostridium chauvoei (C. chauvoei).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridium chauvoei (C. chauvoei).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call